ESSA Pharma
About:
ESSA Pharma is a biotechnology company that develops new drugs for prostate cancer.
Website: http://www.essapharma.com
Twitter/X: essapharma
Top Investors: Pfizer, Deerfield, Biotechnology Value Fund, Silicon Valley Bank, Frazier Healthcare Partners
Description:
ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. ESSA is developing drugs that selectively block the N-terminal domain of the androgen receptor (AR). The AR is required for the growth and survival of most prostate cancer; therefore, the AR N-terminal domain is an ideal target for next-generation hormone therapy.
$281M
$10M to $50M
Vancouver, British Columbia, Canada
2009-01-01
info(AT)essapharma.com
Marianne Sadar, Raymond Andersen
11-50
2022-07-08
Public
© 2025 bioDAO.ai